Finance

Beta
Lists
ZLD:ASX
Zelira Therapeutics Ltd
A$0.50
0.00%
(0.00) 1D
Feb 27, 2:55:35 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for ZLD...
Mkt. cap
5.95M
Avg. vol.
0.00
Volume
0.00
52-wk high
A$1.15
52-wk low
A$0.31
EPS
-A$0.32
Shares outstanding
755.34M
No. of employees
8
Mkt. cap
5.95M
Avg. vol.
0.00
Volume
0.00
52-wk high
A$1.15
52-wk low
A$0.31
EPS
-A$0.32
Shares outstanding
755.34M
No. of employees
8
News stories
From sources across the web
About Zelira Therapeutics Ltd
CEOOludare Odumosu
Employees8
Founded2003
Headquarters-
SectorPharmaceutical industry
Websitezeliratx.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
328.00
328.00
-
-
Cost of goods sold
1.38K
1.38K
400.42K
400.42K
Cost of revenue
1.38K
1.38K
400.42K
400.42K
Research and development expenses
705.93K
705.93K
626.38K
626.38K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
521.79K
521.79K
314.23K
314.23K
Operating expense
729.85K
729.85K
1.03M
1.03M
Total operating expenses
731.23K
731.23K
1.43M
1.43M
Operating income
-730.90K
-730.90K
-1.43M
-1.43M
Other non operating income
-85.97K
-85.97K
525.32K
525.32K
EBT including unusual items
-1.24M
-1.24M
-682.66K
-682.66K
EBT excluding unusual items
-1.24M
-1.24M
-682.66K
-682.66K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
47.85K
47.85K
1.39K
1.39K
Net income
-1.21M
-1.21M
-608.62K
-608.62K
Net profit margin
-367,475.61%
-367,475.61%
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
221.69K
221.69K
Interest expense
-425.30K
-425.30K
-
-
Net interest expenses
-425.30K
-425.30K
221.69K
221.69K
Depreciation and amortization charges
75.05K
75.05K
60.19K
60.19K
EBITDA
-686.81K
-686.81K
-1.40M
-1.40M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer